175 related articles for article (PubMed ID: 24533675)
1. Ranolazine for the suppression of ventricular arrhythmia: a case series.
Yeung E; Krantz MJ; Schuller JL; Dale RA; Haigney MC
Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):345-50. PubMed ID: 24533675
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
Nanda S; Levin V; Martinez MW; Freudenberger R
Pacing Clin Electrophysiol; 2010 Dec; 33(12):e119-20. PubMed ID: 20345626
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
[TBL] [Abstract][Full Text] [Related]
4. Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
Kaliebe JW; Murdock DK
WMJ; 2009 Oct; 108(7):373-5. PubMed ID: 19886587
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
Robinson CG; Samson PP; Moore KMS; Hugo GD; Knutson N; Mutic S; Goddu SM; Lang A; Cooper DH; Faddis M; Noheria A; Smith TW; Woodard PK; Gropler RJ; Hallahan DE; Rudy Y; Cuculich PS
Circulation; 2019 Jan; 139(3):313-321. PubMed ID: 30586734
[TBL] [Abstract][Full Text] [Related]
6. Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
Nieminen T; Scirica BM; Pegler JR; Tavares C; Pagotto VP; Kanas AF; Sobrado MF; Nearing BD; Umez-Eronini AA; Morrow DA; Belardinelli L; Verrier RL
Am J Cardiol; 2014 Jul; 114(1):17-23. PubMed ID: 24852915
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
8. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Scirica BM; Morrow DA; Hod H; Murphy SA; Belardinelli L; Hedgepeth CM; Molhoek P; Verheugt FW; Gersh BJ; McCabe CH; Braunwald E
Circulation; 2007 Oct; 116(15):1647-52. PubMed ID: 17804441
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm.
Vizzardi E; D'Aloia A; Salghetti F; Aljassim O; Raweh A; Bonadei I; Bontempi L; Curnis A
Drug Discov Ther; 2013 Feb; 7(1):43-5. PubMed ID: 23524943
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine therapy in drug-refractory ventricular arrhythmias.
Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study.
Bertels RA; Kammeraad JAE; Zeelenberg AM; Filippini LH; Knobbe I; Kuipers IM; Blom NA
Pediatr Cardiol; 2021 Apr; 42(4):883-890. PubMed ID: 33515328
[TBL] [Abstract][Full Text] [Related]
12. Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
Hyman MC; Mustin D; Supple G; Schaller RD; Santangeli P; Arkles J; Lin D; Muser D; Dixit S; Nazarian S; Epstein AE; Callans DJ; Marchlinski FE; Frankel DS
Heart Rhythm; 2018 Feb; 15(2):159-163. PubMed ID: 29405947
[TBL] [Abstract][Full Text] [Related]
13. Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
Murdock DK; Kaliebe J; Overton N
Pacing Clin Electrophysiol; 2008 Jun; 31(6):765-8. PubMed ID: 18507552
[TBL] [Abstract][Full Text] [Related]
14. Ventricular tachycardia originating from the septal papillary muscle of the right ventricle: electrocardiographic and electrophysiological characteristics.
Santoro F; DI Biase L; Hranitzky P; Sanchez JE; Santangeli P; Perini AP; Burkhardt JD; Natale A
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):145-50. PubMed ID: 25229319
[TBL] [Abstract][Full Text] [Related]
15. The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel.
Kloner RA; Dow JS; Bhandari A
Cardiovasc Ther; 2011 Aug; 29(4):e36-41. PubMed ID: 20626400
[TBL] [Abstract][Full Text] [Related]
16. Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial.
Younis A; Goldenberg I; Farooq S; Yavin H; Daubert J; Raitt M; Mazur A; Huang DT; Mitchell BL; Rashtian MR; Winters S; Vloka M; Aktas M; Bernabei MA; Beck CA; McNitt S; Zareba W
JACC Clin Electrophysiol; 2022 Jun; 8(6):754-762. PubMed ID: 35738852
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.
Dhalla AK; Wang WQ; Dow J; Shryock JC; Belardinelli L; Bhandari A; Kloner RA
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1923-9. PubMed ID: 19767532
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study.
Zhong L; Lee YH; Huang XM; Asirvatham SJ; Shen WK; Friedman PA; Hodge DO; Slusser JP; Song ZY; Packer DL; Cha YM
Heart Rhythm; 2014 Feb; 11(2):187-93. PubMed ID: 24157533
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic properties of ranolazine--from bench to bedside.
Tzeis S; Andrikopoulos G
Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
[TBL] [Abstract][Full Text] [Related]
20. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
